Engaging Men in Prevention and Care for HIV/AIDS in Africa
article has not abstract
Published in the journal:
. PLoS Med 9(2): e32767. doi:10.1371/journal.pmed.1001167
Category:
Essay
doi:
https://doi.org/10.1371/journal.pmed.1001167
Summary
article has not abstract
Summary Points
-
The HIV/AIDS response in Africa has always had a gender focus; targeted efforts have reduced the impact of the epidemic on women and children.
-
The response has been far less successful for the treatment of men: there is less ART coverage of men than women in Africa, and men typically have higher mortality. Men also tend to present at clinic with advanced disease and are more likely to be lost to follow-up.
-
Yet, efforts to understand men's healthseeking behaviour are poorly understood in the AIDS epidemic, and encouraging men to get tested and treated is a major challenge, but one that is poorly recognized.
-
We review the emerging evidence and we call for a balanced approach to gender programming in an effort to involve both men and women in treatment and prevention.
Antiretroviral therapy (ART) saves lives and prevents new HIV/AIDS infections [1]. Successful efforts to increase the number of people receiving ART create important public health challenges, some of which may be considered counter-intuitive. One of the largest challenges for ART provision has been targeting populations most affected by HIV/AIDS and most vulnerable to the effects of the disease. In Africa, the focus of the epidemic has historically been on women and children. Women are considered to be particularly vulnerable to HIV infection in this setting because of biological factors, their reduced sexual autonomy, and men's sexual power and privilege over them. [2]–[6]. This understanding has led HIV/AIDS public health prevention and treatment campaigns to focus on women and children in this setting. As a result, men have received considerably less attention in the epidemic [7] and receive less targeted HIV prevention and treatment programs [5].
Targeting men in prevention and treatment, however, may have a large impact on mortality, new infections, and the economic impact of HIV/AIDS in Africa. In the wake of the HPTN 052 trial results, demonstrating 96% (95% confidence interval, 73%–99%) efficacy of prevention in discordant couples with earlier ART treatment initiation, engaging greater numbers of men with HIV in treatment could have important prevention benefits for women and girls, and for primary prevention of vertical transmission [1].
Neglect of Men in HIV Prevention and Treatment Campaigns
In the last half-decade, there has been discussion over the need to actively engage men in sub-Saharan Africa in HIV prevention campaigns. Several randomized trials in South Africa have examined interventions aimed at male behavior change [8]–[12]. Further work has come from the social science disciplines, where researchers and gender advocates have created gender-focused HIV prevention frameworks and contextualized the role of men in contributing to the epidemic [5],[13],[14]. Although much of this work has examined attitudes and behaviors, there is emerging recognition from a number of epidemiological sources that men in sub-Saharan Africa face important challenges in terms of HIV vulnerability, engagement and retention in care, and access to ART that affect mortality [15],[16]. Taken together, the evidence indicates that men are under-represented in HIV testing, treatment, and care, and this likely has a direct impact on outcomes of care [17]–[21].
While public health efforts have been aimed at women, particularly child-bearing women (e.g., HIV testing, care, and treatment opportunities provided through antenatal care services), scale-up efforts are hindered by the differences in health-seeking behaviors between men and women [22]. For instance, sickness may be seen as a sign of weakness for many men, and this perception has resulted in a reluctance of care-seeking among men [23]. There is also evidence indicating that men may feel that they have been caught at their hidden sexual behaviors and so they avoid HIV testing [23]. Additionally, employment-related migration will keep men away from their partner and families for long time periods, and this absence may make them more vulnerable to HIV infection due to sexual exposure, drug and alcohol use, and delinkages with local health services [22]. The reality that men are less likely to seek health care is intimately linked to perceptions of masculinity, and is generally considered to be part of the same phenomenon that drives multiple partnering, violence against women, substance use, and homophobia among men [5],[13].
There is now also a growing appreciation that the HIV/AIDS epidemic in Africa is driven by complex and poorly understood sexual dynamics that include, among others, concurrent partner relationships and multiple partner relationships involving both males and females [24]–[26]. The available evidence indicates that infection is equally balanced between males and females in most heterosexual settings [25].
Failing to engage men in HIV prevention and treatment may also have an impact on household family income. In Africa, men are typically the larger income-generators, often engaged in employment outside of the home, whereas women are more likely to be engaged in economic activities closer to home as well as child caring. If the head male member contracts HIV and does not receive the appropriate care, ill health or death of this individual can severely impact household family income.
While our discussion here is predominantly focused on heterosexual men, we cannot ignore that men who have sex with other men (MSM) are one of the most difficult groups to target in prevention and treatment campaigns in Africa. Data on the magnitude of MSM or the prevalence of HIV in this population are sparse [27]. The recent crackdown on MSM in Uganda, where the government petitioned a law before parliament to make MSM sexual activities illegal, potentially punishable by death for those who are HIV positive, demonstrates that certain male groups require specific care and support [28]. The law, largely condemned around the world, also placed pressure on HIV/AIDS service providers, as anyone, including organizations, aware of homosexual activity and failing to report the act could be punished with up to three years of imprisonment. With the popular support the bill has received, HIV/AIDS service organizations have been challenged to provide strong advice to their employees on how to treat MSM patients. Similar legal and cultural oppression of MSM occurs in other African countries.
The Magnitude of HIV/AIDS-Related Mortality by Gender
The gender differences inherent in the health-seeking behaviors of men and women, and the historical gender-specific efforts in HIV-related public health campaigns in this region, impact health outcomes, including mortality [16],[17],[29]. For instance, recent cohort studies conducted among individuals starting ART in sub-Saharan Africa have indicated that men tend to access ART at a later disease stage than women, and the risk of mortality once on ART is much higher for men than women, even when adjusting for disease state [15],[30]. Specifically, in Uganda, evidence from a large, nationally representative cohort study indicates that men are (hazard ratio, HR) 1.43 (95% confidence interval: 1.31–1.57) times more likely to die than women [30], and in South Africa, evidence from a large cohort study indicates that men are 1.47 (HR, 95% confidence interval: 1.27–1.72) times more likely to die than women [15]. Using these estimates, and demographic input assumptions and population estimates [31],[32], HIV prevalence [33]–[35], and the number of individuals receiving ART [36]–[40], we can develop a simple projection model to estimate HIV/AIDS-related mortality by gender for the two counties. Assuming that these estimates remain constant, a crude mortality projection from 2004–2015 indicates that the cumulative number of national HIV/AIDS-related deaths for those aged 15–49 years is much higher among males when compared to females in both Uganda (475,986 cumulative number of deaths for males versus 204,674 cumulative number of deaths for females) and South Africa (2,488,286 cumulative number of deaths for males versus 1,169,494 cumulative number of deaths for females). (Please contact the primary author for a complete description of the model assumptions.)
Targeted Prevention
Although there have been efforts to involve men at antenatal clinics, these have had mixed results in terms of HIV prevention [41]. There are examples of HIV prevention programs in Africa that have intentionally targeted men in their campaigns to change sexual behaviors [42]–[46]. However, they are predominantly concerned with primary prevention, and rarely consider treatment interventions. A small body of evidence is emerging indicating that programs integrated into the workplace and programs that offer peer education may be successful at engaging African men in HIV testing, care, and treatment [47].
Funding agencies should recognize that males and females are both severely affected by the epidemic in differing ways, and should plan for interventions that engage both men and women. Funding agencies, such as the US President's Emergency Plan for AIDS Relief (PEPFAR), frequently allocate funding according to priority groups, particularly women and children [48]. Targeted and sustainable funding may result in important lessons learned.
Targeting specific populations for ART treatment and care can have important residual effects on preventing transmission to other populations. The HPTN 052 trial confirmed findings from observational studies that ART has a large preventive impact on sexual partners [1]. Given the economic reality, scaling up access to ART as a prevention strategy will be a challenge due to costs, human resources constraints, and prioritizing recipients; targeting those individuals and groups who are most likely to transmit the virus, core transmitters, may be a first step in using ART treatment as prevention in a scaled up manner. It is also likely that male circumcision clinics, slowly growing in number in sub-Saharan Africa, would be ideal venues to test men for HIV, and provide them with appropriate referrals for care and treatment. Mobile approaches to testing targeted at venues, including work spaces, frequented by men may also have significant impacts on increasing male engagement in prevention and treatment. This approach has been demonstrated by the success of HPTN 043 (Project Accept) reported in 2011, that markedly increased male acceptance of testing in four countries (South Africa, Zimbabwe, Tanzania, and Thailand) [49]. Targeted treatment of all individuals who are HIV positive and in a relationship or sexually active will reduce their viremia and reduce their potential to infect others [50].
The epidemiological evidence is accumulating, and indicates that males in sub-Saharan Africa are not accessing HIV services as often as their female counterparts, and as a result, men have worse outcomes of care, including mortality. Funding organizations need to recognize the social and health impacts associated with not engaging men in primary and secondary HIV prevention campaigns. Programmatic efforts should account for this disparity, and recognize that it may be necessary to seek out men for HIV testing, care, and ART in variety of settings, and through mechanisms that that take into consideration the local culture and gender roles in partnerships, sex, and health.
Zdroje
1. CohenMSChenYQMcCauleyMGambleTHosseinipourMC 2011 Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365 493 505
2. Joint United Nations Programme on HIV/AIDS UPF, UN Development Fund for Women 2004 Women and HIV/AIDS: confronting the crisis New York UN Population Fund
3. KrishnanSDunbarMMinnisAMedlinCGerdtsC 2008 Poverty, gender inequities, and women's risk of human immunodeficiency virus/AIDS. Ann N Y Acad Sci 1136 101 110
4. OjikutuBStoneV 2005 Women, inequality, and the burden of HIV. N Engl J Med 352 649 652
5. HigginsJHoffmanSDworkinS 2010 Rethinking gender, hetersexual men, and women's vulnerability to HIV/AIDS. Am J Public Health 100 435 445
6. GuptaG 2002 How men's power over women fuels the HIV epidemic. BMJ 324 183 184
7. ExnerTGardosPSealDEhrhadrtA 1999 HIV sexual risk interventions with hetersexual men: the forgotten group. AIDS Behaviour 3 347 358
8. KalichmanSCCainDEatonLJoosteSSimbayiLC 2011 Randomized clinical trial of brief risk reduction counseling for sexually transmitted infection clinic patients in Cape Town, South Africa. Am J Public Health 101 e9 e17
9. KalichmanSCSimbayiLCCloeteAClayfordMArnoldsW 2009 Integrated gender-based violence and HIV Risk reduction intervention for South African men: results of a quasi-experimental field trial. Prev Sci 10 260 269
10. KalichmanSCRompaDCageM 2005 Group intervention to reduce HIV transmission risk behavior among persons living with HIV/AIDS. Behav Modif 29 256 285
11. DunkleKLJewkesRKNdunaMLevinJJamaN 2006 Perpetration of partner violence and HIV risk behaviour among young men in the rural Eastern Cape, South Africa. AIDS 20 2107 2114
12. JewkesRNdunaMLevinJJamaNDunkleK 2008 Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ 337 a506
13. DworkinSDunbarMKrishnanSHatcherASawiresS 2011 Uncovering tensions and capitalizing on synergies in HIV/AIDS and antiviolence programs. Am J Public Health 101 995 1003
14. DunkleKJewkesR 2007 Effective HIV prevention requires gender-transformative work with men. Sex Transm Infect 83 173 174
15. MayMBoulleAPhiriSMessouEMyerL 2010 Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet 376 449 457
16. JohannessenA 2011 Are men the losers of the antiretroviral treatment scale-up? AIDS 25 1225 1226
17. HawkinsCChalamillaGOkumaJSpiegelmanDHertzmarkE 2011 Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting. AIDS 25 1189 1197
18. BraitsteinPBrinkhofMWDabisFSchechterMBoulleA 2006 Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367 817 824
19. BraitsteinPBoulleANashDBrinkhofMWDabisF 2008 Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt) 17 47 55
20. Ochieng-OokoVOchiengDSidleJEHoldsworthMWools-KaloustianK 2010 Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bull World Health Organ 88 681 688
21. MuulaASNgulubeTJSiziyaSMakupeCMUmarE 2007 Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health 7 63
22. ManePAggletonP 2001 Gender and HIV/AIDS: what do men have to do with it? Current Sociology 49 23 37
23. United Nations Integrated Regional Information Networks (IRIN) 2006 Uganda: men's union encourages men to be more open about HIV. United Nations Integrated Regional Information Networks
24. EpsteinHSwidlerAGrayRReniersGParkerW 2010 Measuring concurrent partnerships. Lancet 375 1869; author reply 1870
25. EyawoOde WalqueDFordNGakiiGLesterRT 2010 HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis 10 770 777
26. PadianNManianS 2011 The concurrency debate: time to put it to rest. Lancet 378 203 204
27. van GriensvenFde Lind van WijngaardenJWBaralSGrulichA 2009 The global epidemic of HIV infection among men who have sex with men. Curr Opin HIV AIDS 4 300 307
28. AlsopZ 2009 Ugandan bill could hinder progress on HIV/AIDS. Lancet 374 2043 2044
29. IngleSMMayMUebelKTimmermanVKotzeE 2010 Differences in access and patient outcomes across antiretroviral treatment clinics in the Free State province: a prospective cohort study. S Afr Med J 100 675 681
30. MillsEJBakandaCBirungiJChanKHoggRS 2011 Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda. J Int AIDS Soc 14 52
31. United States Agency for International Development 2009 Health Policy Initiative. AIM: a computer program for making HIV/AIDS projections and examining the demographic and social impacts of AIDS. Available: http://data.unaids.org/pub/Manual/2009/20090414_aim_manual_2009_en.pdf. Accessed 28 December 2011
32. United States Agency for International Development (USAID) 2007 Health Policy Initiative. DemProj: a computer program for making population projections. Available: http://data.unaids.org/pub/Manual/2007/demproj_2007_en.pdf. Accessed 28 December 2011
33. Health Systems Trust 2011 Recently updated indicators. HIV prevalence (%) (age 15–49). Available: http://indicators.hst.org.za/healthstats/293. Accessed 28 December 2011
34. Joint United Nations Programme on HIV/AIDS (UNAIDS) 2008 Epidemiological fact sheet on HIV and AIDS: South Africa. Available: http://apps.who.int/globalatlas/predefinedReports/EFS2008/full/EFS2008_ZA.pdf. Accessed 10 January 2012
35. Joint United Nations Programme on HIV/AIDS (UNAIDS) 2008 Epidemiological fact sheet on HIV and AIDS: Uganda. Available: http://apps.who.int/globalatlas/predefinedReports/EFS2008/full/EFS2008_UG.pdf. Accessed 10 January 2012
36. World Health Oganization (WHO), Joint United Nations Programme on HIV/AIDS (UNAIDS), United Nations Children's Fund (UNICEF) 2010 Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2010. Available: http://www.who.int/hiv/pub/2010progressreport/report/en/index.html. Accessed 28 December 2011
37. World Health Oganization (WHO), Joint United Nations Programme on HIV/AIDS (UNAIDS), United Nations Children's Fund (UNICEF) 2009 Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009. Available: http://www.who.int/hiv/pub/2009progressreport/en/. Accessed 28 December 2011
38. World Health Oganization (WHO), Joint United Nations Programme on HIV/AIDS (UNAIDS), United Nations Children's Fund (UNICEF) 2008 Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2008. Available: http://www.who.int/hiv/pub/2008progressreport/en/index.html. Accessed 28 December 2011
39. World Health Oganization (WHO), Joint United Nations Programme on HIV/AIDS (UNAIDS), United Nations Children's Fund (UNICEF) 2007 Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2007. Available: http://www.who.int/hiv/pub/2007progressreport/en/index.html. Accessed 28 December 2011
40. World Health Oganization (WHO), Joint United Nations Programme on HIV/AIDS (UNAIDS), United Nations Children's Fund (UNICEF) 2006 Progress on global access to HIV antiretroviral therapy: a report on 3 by 5 and beyond. Available: http://www.who.int/hiv/pub/2006progressreport/en/. Accessed 28 December 2011
41. BarkerGRicardoCNascimientoM 2007 Engaging men and boys in changing gender-based inequity in health: evidence from programme interventions. http://www.who.int/gender/documents/Engaging_men_boys.pdf. Geneva: World Health Organization
42. HutchinsonSWeissEBarkerGSagundiMPulerwitzJ 2004 Involving young men in HIV prevention programs: operations research on gender-based approaches in Brazil, Tanzania, and India. Horizons Rep Dec 1 6
43. PeacockDLevackA 2004 The men as partners program in South Africa: reaching men to end gender-based violence and promote sexual and reporductive health. Int J Mens Health 3 173 188
44. Sonke Gender Justice 2007 One Man Can workshop activities: talking to men about gender, sexual and domestic violence, and HIV/AIDS. Available http://www.genderjustice.org.za/onemancan/download-the-toolkit/2.html. Accessed 28 December 2011
45. Sonke Gender Justice 2008 One Man Can: working with men—essential to reducing the spread and impact of gender based violence and HIV and AIDS in Southern Africa. Available: http://www.genderjustice.org.za/onemancan/images/publications/factsheet/factsheet_eng.pdf. Accessed 28 December 2011
46. JewkesRNdunaMLevinJJamaNDunkleK 2006 A cluster randomized-controlled trial to determine the effectiveness of Stepping Stones in preventing HIV infections and promoting safer sexual behaviour amongst youth in the rural Eastern Cape, South Africa: trial design, methods and baseline findings. Trop Med Int Health 11 3 16
47. KuwaneBAppiahKFelixMGrantAChurchyardG 2009 Expanding HIV care in Africa: making men matter in Johannesburg. Lancet 374 1329
48. BirungiJMillsEJ 2010 Can we increase male involvement in AIDS treatment? Lancet 376 1302
49. SweatMMorinSCelentanoDMulawaMSinghB 2011 Community-based intervention to increase HIV testing and case detection in people aged 16–32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis 11 525 532
50. LimaVDJohnstonKHoggRSLevyARHarriganPR 2008 Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis 198 59 67
Štítky
Interní lékařstvíČlánek vyšel v časopise
PLOS Medicine
2012 Číslo 2
- Není statin jako statin aneb praktický přehled rozdílů jednotlivých molekul
- Dlouhodobě úspěšná léčba obstrukční hypertrofické kardiomyopatie pomocí mavakamtenu – kazuistika
- Moje zkušenosti s Magnosolvem podávaným pacientům jako profylaxe migrény a u pacientů s diagnostikovanou spazmofilní tetanií i při normomagnezémii - MUDr. Dana Pecharová, neurolog
- Antikoagulační léčba u pacientů před operačními výkony
- Definice a klasifikace chronického onemocnění ledvin dle KDIGO
Nejčtenější v tomto čísle
- The Activities of Current Antimalarial Drugs on the Life Cycle Stages of : A Comparative Study with Human and Rodent Parasites
- Association between Clean Delivery Kit Use, Clean Delivery Practices, and Neonatal Survival: Pooled Analysis of Data from Three Sites in South Asia
- Prevalence, Distribution, and Impact of Mild Cognitive Impairment in Latin America, China, and India: A 10/66 Population-Based Study
- Characterisation of Hospital Ward–Based Transmission Using Extensive Epidemiological Data and Molecular Typing